Skip to main content
. 2020 Dec 24;13(1):39. doi: 10.3390/nu13010039

Figure 1.

Figure 1

Kaplan–Meier estimates of the cumulative probability of COVID-19 participants’ survival according to the regular use of vitamin K antagonist (VKA) prior to COVID-19 (n = 82).